After blood vessel damage, effective blood clotting is essential to halt bleeding. However, this process is inefficient in ...

Attempting to decode the mysterious "why" of our human existence has been a trend since, well, forever. To do so, some look ...

Following a lawsuit over a teen suicide and an FTC investigation, OpenAI is working on an age-prediction system to block ...

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...

Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response Rate (ORR) at the Highest Dose Level (100 µg) and a 40% ORR at the ...

Worldwide interest in artificial intelligence (AI)-enabled, touch-free wearables is booming as users demand more fluid, intuitive ways to engage ...

Ideal Automotive aims to create a brand new product that has never existed in this world," said Li Xiang, Chairman and CEO of ...

Detailed price information for Maze Therapeutics Inc (MAZE-Q) from The Globe and Mail including charting and trades.

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...

The case is filed under Suit No. FHC/L/CV/1775/25, between: Ms. Amaka Obasi as the applicant and the Inspector General of Police, the Nigerian Police, Mr. Divine Ikubor a.k.a. Rema, and Mr. Sean Okeke ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...

Oruka Therapeutics presents positive interim phase 1 results for ORKA-001 at EADV Congress: Menlo Park, California Thursday, September 18, 2025, 18:00 Hrs [IST] Oruka Therapeutics ...